<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513309/" ref="ordinalpos=4363&amp;ncbi_uid=4428464&amp;link_uid=PMC3513309" image-link="/pmc/articles/PMC3513309/figure/pone-0050221-g003/" class="imagepopup">Figure 3. Separate comparison of gene expression post-treatment versus gene expression pre-treatment for responding and non-responding patients. Ingenuity <span class="highlight" style="background-color:">pathway</span> analysis suggests differences in regulation of T-cell (Figure 3A) and B-cell (Figure 3B) receptor <span class="highlight" style="background-color:">signaling</span>..  From: Gene Expression Profile of Peripheral Blood Lymphocytes from Renal Cell Carcinoma Patients Treated with IL-2, Interferon-? and Dendritic Cell Vaccine. </a></div><br /><div class="p4l_captionBody">Most of the molecules in the B-cell as well as in the T-cell receptor pathway are down-regulated for non-responding patients upon immunotherapy (POST &lt;PRE), whereas gene expression of the same molecules is up-regulated for responding patients (POST &gt;PRE). Red: up-regulation, Green: down-regulation.</div></div>